Xlife Sciences AG Cash Flow Quality Index
Xlife Sciences AG cash flow quality index. Xlife Sciences AG (XLS) has a Cash Flow Quality Index of -0.01x as of December 2024. Operating cash flow of CHF-421.51K is below net income of CHF28.71 Million, suggesting accrual-heavy earnings not yet converted to cash. See Xlife Sciences AG financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Xlife Sciences AG (2019–2024)
Cash flow quality index of Xlife Sciences AG from 2019 to 2024. Historical Cash Flow Quality Index for Xlife Sciences AG across 6 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore Xlife Sciences AG (XLS) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Xlife Sciences AG Cash Flow Quality Index by Year (2019–2024)
Xlife Sciences AG cash flow quality index by year from 2019 to 2024. Year-by-year earnings quality comparison for Xlife Sciences AG. For the full cash flow conversion analysis, see Xlife Sciences AG (XLS) cash conversion ratio.
| Year | Quality Index | Operating CF (CHF) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | -0.01x | CHF-421.51K | CHF34.28 Million | ▼ -206.5% |
| 2023 | 0.01x | CHF171.78K | CHF14.88 Million | ▲ +103.6% |
| 2022 | -0.32x | CHF-4.61 Million | CHF14.31 Million | ▼ -297.7% |
| 2021 | -0.08x | CHF-4.32 Million | CHF53.42 Million | ▼ -335.9% |
| 2020 | -0.02x | CHF-401.55K | CHF21.62 Million | ▲ +95.2% |
| 2019 | -0.39x | CHF-398.24K | CHF1.03 Million | — |